For breast cancer patients with a positive sentinel node biopsy (SNB), skipping axillary lymph node dissection (ALND) in favor of axillary radiotherapy (ART) results in similar outcomes without the harmful side effects of surgery, according to the results of the AMAROS trial reported at the American Society of Clinical Oncology meeting in Chicago.

Many studies have maintained that the most advanced SPECT cameras can significantly reduce patient dose, but what about medical staff? A new protocol of myocardial perfusion SPECT imaging combines state-of-the-art detector technology, image reconstruction and stress-only imaging, all precipitating an up to 60 percent drop in radiation exposure to healthcare workers, according to a study published May 30 in the Journal of Nuclear Medicine.

Breast density has received national attention from the New York and California density inform bills going into effect and the passage of the Hawaii, Maryland, Tennessee and Alabama bills.  With significant coverage of studies evaluating the impact of dense breast tissue on cancer screening, it seems that breast density is in the news nearly every day.

In the setting of concurrent chemotherapy, high-dose radiotherapy did not improve survival of patients with stage III non-small-cell lung cancer (NSCLC) compared with treatment featuring standard-dose radiotherapy, according to the results of a randomized phase III clinical trial to be presented June 4 at the American Society of Clinical Oncology 2013 annual meeting in Chicago.

Meeting the demands of changing patient needs, Toshiba America Medical Systems, Inc. will be showcasing the AplioTM 500, Aplio 300 and ViamoTM ultrasound systems at this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM), May 30 to June 1, 2013, in San Francisco (Booth #717).

UltraSPECT, a leading provider of nuclear medicine (NM) image reconstruction technology that reduces radiopharmaceutical dose and acquisition time, announces today the installation of its proprietary Wide Beam Reconstruction (WBR™) software at nearly ten healthcare facilities.

Barco, a global leader in healthcare imaging technology, is supplying Swedish Covenant with several Mammo Tomosynthesis 5MP display systems to enable the facility to offer 3D mammography to patients. As the first hospital in downtown Chicago with this capability, Swedish Covenant is making this service available to a socioeconomically diverse population of women who need or desire a higher-level breast screening exam.

Molecular imaging has been in a growth phase since 2010, spurred by emerging markets and demand for hybrid and other cutting edge scanner and biomarker technologies, according to a market report profiling the most recent developments in molecular imaging published in April by UK-based Espicom Business Intelligence.